Compare AANJANEYA LIFECARE with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS NOVARTIS DR. DATSONS LABS/
NOVARTIS
 
P/E (TTM) x -10.9 1,959.2 - View Chart
P/BV x 0.2 26.0 0.6% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 DR. DATSONS LABS   NOVARTIS
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
NOVARTIS
Mar-19
DR. DATSONS LABS/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs126980 12.8%   
Low Rs31600 5.1%   
Sales per share (Unadj.) Rs133.0198.7 66.9%  
Earnings per share (Unadj.) Rs0.221.0 0.7%  
Cash flow per share (Unadj.) Rs6.622.3 29.7%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8307.5 41.9%  
Shares outstanding (eoy) m31.6624.69 128.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.0 14.8%   
Avg P/E ratio x516.137.7 1,369.7%  
P/CF ratio (eoy) x11.835.5 33.4%  
Price / Book Value ratio x0.62.6 23.6%  
Dividend payout %047.7 0.0%   
Avg Mkt Cap Rs m2,47719,508 12.7%   
No. of employees `000NA0.6 0.0%   
Total wages/salary Rs m561,171 4.8%   
Avg. sales/employee Rs ThNM8,445.4-  
Avg. wages/employee Rs ThNM2,015.7-  
Avg. net profit/employee Rs ThNM891.0-  
INCOME DATA
Net Sales Rs m4,2114,907 85.8%  
Other income Rs m79783 10.1%   
Total revenues Rs m4,2895,689 75.4%   
Gross profit Rs m569123 463.0%  
Depreciation Rs m20432 642.8%   
Interest Rs m43016 2,705.7%   
Profit before tax Rs m13858 1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6340 1.8%   
Profit after tax Rs m5518 0.9%  
Gross profit margin %13.52.5 539.6%  
Effective tax rate %48.039.6 121.2%   
Net profit margin %0.110.6 1.1%  
BALANCE SHEET DATA
Current assets Rs m6,8528,055 85.1%   
Current liabilities Rs m6,7111,850 362.7%   
Net working cap to sales %3.3126.4 2.6%  
Current ratio x1.04.4 23.5%  
Inventory Days Days16145 357.3%  
Debtors Days Days31834 939.1%  
Net fixed assets Rs m3,673150 2,451.9%   
Share capital Rs m317123 256.6%   
"Free" reserves Rs m3,7617,469 50.4%   
Net worth Rs m4,0787,592 53.7%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6339,824 128.6%  
Interest coverage x1.054.9 1.9%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.5 66.7%   
Return on assets %3.45.4 63.4%  
Return on equity %0.16.8 1.7%  
Return on capital %7.711.5 66.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96458 1,673.6%   
Fx outflow Rs m6071,326 45.8%   
Net fx Rs m357-1,269 -28.1%   
CASH FLOW
From Operations Rs m1,345-1,943 -69.2%  
From Investments Rs m-2,2562,742 -82.3%  
From Financial Activity Rs m-1,200-298 402.3%  
Net Cashflow Rs m-2,111501 -421.0%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 2.0 -  
FIIs % 1.4 1.6 84.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.5 437.7%  
Shareholders   20,807 41,647 50.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS